Total number of studies | 24 |
Low NIHSS definitions | |
≤5 | 15 (63%) |
≤7 | 3 (13%) |
≤8 | 4 (17%) |
Other | 2 (8%) |
EVT feasibility studies (from six studies) | |
mTICI ≤2b | 78–97% |
sICH | 0–10% |
EVT vs BMM | |
Primary outcome showed EVT benefit | 4 of 10 studies |
sICH EVT risk significant | 6 of 10 studies |
EVT vs IVT | |
Primary outcome showed EVT benefit | 0 of 4 studies |
sICH EVT risk significant | 0 of 4 studies |
BMM, best medical management; EVT, endovascular therapy; IVT, intravascular thrombolysis; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage.